-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ljz3v5OyCik7nWQTNiNb2F9cRzEqPYjk6QgbkVKHD5Y+lHKIp3KIzZU1Q0QKJmsK MCijEsMa7csjHZGfBgCevw== 0000891836-99-000102.txt : 19990218 0000891836-99-000102.hdr.sgml : 19990218 ACCESSION NUMBER: 0000891836-99-000102 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19990217 ITEM INFORMATION: FILED AS OF DATE: 19990217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MALLINCKRODT INC /MO CENTRAL INDEX KEY: 0000051396 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 361263901 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-00483 FILM NUMBER: 99544706 BUSINESS ADDRESS: STREET 1: 675 MCDONNELL BLVD STREET 2: PO BOX 5840 CITY: ST LOUIS STATE: MO ZIP: 63134 BUSINESS PHONE: 3146542000 MAIL ADDRESS: STREET 1: 7733 FORSYTH BLVD CITY: ST LOUIS STATE: MO ZIP: 63105-1820 FORMER COMPANY: FORMER CONFORMED NAME: MALLINCKRODT INC /MO DATE OF NAME CHANGE: 19970625 FORMER COMPANY: FORMER CONFORMED NAME: MALLINCKRODT GROUP INC DATE OF NAME CHANGE: 19940322 FORMER COMPANY: FORMER CONFORMED NAME: IMCERA GROUP INC DATE OF NAME CHANGE: 19920703 8-K 1 FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Mallinckrodt Inc - -------------------------------------------------------------------------------- (Exact name of registrant as specified in charter) New York 1-00483 36-1263901 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 675 McDonnell Boulevard, St. Louis, Missouri 63134 - -------------------------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code (314) 654-5200 -------------- - -------------------------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) Item 5. Other Events. See the Registrant's press release, dated February 17, 1999, which is attached hereto as Exhibit 99.1 and which is incorporated herein by reference. (c) Exhibits Exhibit Number Description - -------------- ----------- 99.1 Registrant's press release dated February 17, 1999 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Mallinckrodt Inc. By: /s/ Roger A. Keller --------------------------------------------- Roger A. Keller Vice President, Secretary and General Counsel Date: February 17, 1999 EXHIBIT INDEX Exhibit Number Description - -------------- ----------- 99.1 Registrant's press release dated February 17, 1999 EX-99.1 2 PRESS RELEASE, DATED FEBRUARY 17, 1999 EXHIBIT 99.1 PRESS RELEASE MALLINCKRODT TO REDEEM RIGHTS PLAN; DECLARES QUARTERLY DIVIDEND. ST. LOUIS, Mo., February 17, 1999 - Mallinckrodt Inc. (NYSE:MKG) announced today that it has redeemed the rights issued pursuant to the Rights Agreement, dated Feb. 19, 1996, as amended Sept. 2, 1998, between Mallinckrodt and the First National Bank of Chicago as Rights Agent. Under the terms of the Rights Agreement, shareholders of record as of the Record Date, which will be March 15, 1999, are entitled to receive a redemption payment of five cents per right, or share. Mallinckrodt's directors also declared a dividend of 11.5 cents per share of the company's common stock, payable March 31, 1999 to shareholders of record at the close of business on March 15, 1999. It is the company's intent to recommend to the Board of Directors that the regular quarterly dividend of 16.5 cents per share of common stock be continued in future quarters. Payment of the redemption price of five cents per share of the company's common stock and the dividend of 11.5 cents per share will be mailed on March 31 to the shareholders of record March 15. In August 1998, Mallinckrodt announced it had agreed, in response to concerns raised by some shareholders, that on or before the date of the company's 1999 annual meeting it would either terminate the current rights plan or put the existing plan to a shareholder vote. By terminating the rights plan, C. Ray Holman, chairman and chief executive officer stated "the company's Board of Directors desired to avoid the distraction and expense that would necessarily arise in seeking a shareholder vote. We would prefer to remain totally focused on our goal of building shareholder value through solid growth of the company's businesses." Mallinckrodt's directors also declared the regular $1.00 per share quarterly dividend on Mallinckrodt's 4 percent cumulative preferred stock, payable on March 31, 1999, to shareholders of record at the close of business on March 15, 1999. Based in St. Louis, Mo., Mallinckrodt has three healthcare product groups--Imaging, Pharmaceuticals and Respiratory. The Company operates in more than 100 countries and had fiscal 1998 net sales of $2.4 billion. The Mallinckrodt web site address is www.mallinckrodt.com. -----END PRIVACY-ENHANCED MESSAGE-----